Keywords: bayer, precose, approved, fda, additional, indication, received

Bayer's Precose Approved by FDA For Additional Indication

Article | 12 November 1998

Print This

Bayer has received clearance from the US Food and DrugAdministration to market its antidiabetic Precose (acarbose tablets) for the additional ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in